Cargando…
Clinicopathological significance of nuclear factor (erythroid-2)-related factor 2 (Nrf2) expression in gastric cancer
BACKGROUND: The transcription factor nuclear factor (erythroid-2)–related factor 2 (Nrf2) was originally identified as a critical regulator of intracellular anti-oxidants and of phase II detoxification enzymes through its transcriptional up-regulation of many anti-oxidant response element (ARE)-cont...
Autores principales: | Kawasaki, Yota, Ishigami, Sumiya, Arigami, Takaaki, Uenosono, Yoshikazu, Yanagita, Shigehiro, Uchikado, Yasuto, Kita, Yoshiaki, Nishizono, Yuka, Okumura, Hiroshi, Nakajo, Akihiro, Kijima, Yuko, Maemura, Kosei, Natsugoe, Shoji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302133/ https://www.ncbi.nlm.nih.gov/pubmed/25588809 http://dx.doi.org/10.1186/s12885-015-1008-4 |
Ejemplares similares
-
Clinical utility of perioperative staging laparoscopy for advanced gastric cancer
por: Ishigami, Sumiya, et al.
Publicado: (2014) -
Clinical significance of primary tumor score determined by tumor depth and size in patients with resectable gastric cancer
por: Haraguchi, Naoto, et al.
Publicado: (2018) -
The association of human endogenous retrovirus-H long terminal repeat-associating protein 2 (HHLA2) expression with gastric cancer prognosis
por: Shimonosono, Masataka, et al.
Publicado: (2018) -
A Case of Sudden Onset Septicemia in Recurred Gastric Cancer Following S1 Plus Docetaxel Treatment
por: Ishigami, Sumiya, et al.
Publicado: (2013) -
Programmed death‐ligand 1 is a promising blood marker for predicting tumor progression and prognosis in patients with gastric cancer
por: Amatatsu, Masahiko, et al.
Publicado: (2018)